Publikationen Tina Haase

Publikationen in Peer Review Journals (Stand: September 2021)

Shrivastava, A., Haase, T., Zeller, T., & Schulte, C. (2020). Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs. Frontiers in Cardiovascular Medicine, 7.

Haase, T., Müller, C., Krause, J., Röthemeier, C., Stenzig, J., Kunze, S., ... & Zeller, T. (2018). Novel DNA methylation sites influence GPR15 expression in relation to smoking. Biomolecules, 8(3), 74.

Karakas, M., Haase, T., & Zeller, T. (2018). Linking the sympathetic nervous system to the inflammasome: towards new therapeutics for atherosclerotic cardiovascular disease. European heart journal.

Mangat, R., Borthwick, F., Haase, T., Jacome, M., Nelson, R., Kontush, A., ... & Proctor, S. D. (2018). Intestinal lymphatic HDL miR‐223 and ApoA‐I are reduced during insulin resistance and restored with niacin. The FASEB Journal, 32(3), 1602-1612.

Haase, T., Börnigen, D., Müller, C., & Zeller, T. (2016). Systems medicine as an emerging tool for cardiovascular genetics. Frontiers in cardiovascular medicine, 3, 27.

Zeller, T.*, Haase, T.*,Müller, C.*, Riess, H.*, Lau, D., Zeller, S., ... & Schnabel, R. B. (2015). Molecular characterization of the NLRC4 expression in relation to interleukin-18 levels. Circulation: Cardiovascular Genetics, 8(5), 717-726.

Landgraf, K., Friebe, D., Ullrich, T., Kratzsch, J., Dittrich, K., Herberth, G., ... & Körner, A. (2012). Chemerin as a mediator between obesity and vascular inflammation in children. The Journal of Clinical Endocrinology & Metabolism, 97(4), E556-E564.